|
DDX47 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.901390E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.126000E-01 |
| Normal-vs-Stage2 |
8.171200E-01 |
| Normal-vs-Stage3 |
2.326200E-01 |
| Normal-vs-Stage4 |
1.078420E-01 |
| Stage1-vs-Stage2 |
9.446400E-01 |
| Stage1-vs-Stage3 |
3.070000E-01 |
| Stage1-vs-Stage4 |
1.200580E-01 |
| Stage2-vs-Stage3 |
4.426400E-01 |
| Stage2-vs-Stage4 |
1.581160E-01 |
| Stage3-vs-Stage4 |
4.788400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.158400E-01 |
| Normal-vs-AfricanAmerican |
9.408400E-02 |
| Normal-vs-Asian |
6.630600E-01 |
| Caucasian-vs-AfricanAmerican |
2.704200E-01 |
| Caucasian-vs-Asian |
8.284400E-01 |
| AfricanAmerican-vs-Asian |
8.731800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.630000E-01 |
| Normal-vs-Female |
3.094300E-02 |
| Male-vs-Female |
5.450200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.769800E-01 |
| Normal-vs-Extreme_Weight |
8.561400E-01 |
| Normal-vs-Obese |
1.359390E-01 |
| Normal-vs-Extreme_Obese |
1.300950E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.582400E-01 |
| Normal_Weight-vs-Obese |
2.588600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.328600E-01 |
| Extreme_Weight-vs-Obese |
9.286200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.743600E-01 |
| Obese-vs-Extreme_Obese |
6.922300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.035900E-03 |
| Normal-vs-Age(41-60Yrs) |
8.189700E-02 |
| Normal-vs-Age(61-80Yrs) |
7.356400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.015560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.137000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.840500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.823700E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.253790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.991800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.873040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.087160E-01 |
| Normal-VS-Type2 PRCC |
1.580610E-01 |
| Normal-VS-KIRP CIMP |
8.957200E-03 |
| Normal-VS-Unclassified PRCC |
1.372790E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.880360E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.679000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.814000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.18249999999198E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.814170E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.297600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.901000E-01 |
| Normal-vs-N1 |
1.542050E-02 |
| Normal-vs-N2 |
4.299600E-02 |
| N0-vs-N1 |
2.344900E-03 |
| N0-vs-N2 |
1.154410E-01 |
| N1-vs-N2 |
9.387400E-01 |
|
|
